BioHealth News Archive
What to expect at this CBA Annual Conference
The theme of the 25th CBA Annual (Virtual) Conference is "Innovations amid Crisis: A Productive Year of Biopharma Industry". We will invite biopharmaceutical industry…
Read More
Inno on Fire: The most innovative companies, people in Greater Washington – Washington Business Journal
The finalists are sourced from nominations and editorial coverage, and selected by the DC Inno team. {iframe}https://www.bizjournals.com/washington/news/2020/07/16/dc-inno-on-fire-innovation-in-greater-washington.html?ana=e_me_set1&j=90519354&t=Morning&mkt_tok=eyJpIjoiTXpRMU0ySXdZVEUyT1RKaSIsInQiOiJKQ0I1OGpPVm5KbzdEYXBudHE4YmJhUEd3UTVQM1kyZFdMalVIYm1KcWhiSFFUTHJUbGd6WFJtYXM3WGgydEdIVzg0WlI3TURkT3pHQ0lpVzQxQU5iZ1ZvcVc1WXB4SEtVTW10dUZCRFBCcWcwbm9HTms1UkErdjNJa04yc0w3aSJ9{/iframe}
Read More
Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer | Innate Pharma
Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the appointment of Dr. Joyson Karakunnel as…
Read More
Emergent BioSolutions invests $75M in viral vector, gene therapy capabilities – Homeland Preparedness News
Emergent BioSolutions revealed this week plans to expand its viral vector and gene therapy capabilities. The company announced it will invest $75 million in…
Read More
Digital Health Ecosystem Report: Startups & Companies in 2020 – Business Insider
Healthcare stakeholders can no longer lag on digital transformation, and tapping into innovation can sate convenience-hungry consumers and tackle some massive challenges compressing their…
Read More
How Verona Pharma in Raleigh plans to use $200 million raise – Triangle Business Journal
The raise is one of the biggest in the Triangle since last year. {iframe}https://www.bizjournals.com/triangle/news/2020/07/17/raleigh-firm-verona-pharma-raises-200-million.html{/iframe}
Read More
How America’s Unique Approach To Innovation Can Cure COVID-19
Scientists have responded to COVID-19 with unprecedented speed. Just months after the outbreak of the novel coronavirus, clinical trials are already underway for nearly…
Read More
Save the Date! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Save the Date! 2020 BioHealth Capital Region Forum (2)
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Save the Date! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes – MarketWatch
ROCKVILLE, Md., July 13, 2020 /PRNewswire via COMTEX/ -- ROCKVILLE, Md., July 13, 2020 /PRNewswire/ -- ExeGi Pharma LLC, a U.S.-based company focused on…
Read More
Montgomery County’s unique biohealth and life science organizations are working to test, beat and cure COVID-19 | WTOP
While COVID-19 has thrown the world into an uproar, there’s been a slim silver lining for Maryland. Thanks to a robust group of biohealth…
Read More
U.S. government awards Novavax $1.6 billion for coronavirus vaccine | News | 1450 99.7 WHTC
CHICAGO (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing of a potential vaccine for the novel…
Read More
Alexandria Real Estate Equities, Inc. Announces Pricing Of Upsized Public Offering Of 6,000,000 Shares Of Common Stock
PASADENA, Calif., July 6, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public…
Read More
REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic Neurodegenerative Diseases
ROCKVILLE, Md., July 8, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of…
Read More